Podcast: Managing the Complexities of the EpiPen® Price Increase

Recently, EpiPen’s (epinephrine) manufacturer Mylan has been under increasing scrutiny for skyrocketing the list price to over $600 for a two pack of the drug, an increase of more than 500% since 2007.

Listen as Dr. Rayvelle Stallings, vice president of Government Programs at DST Health Solutions, offers her unique perspective on patient impact, particularly children, from the point of view of a family physician, government programs expert, and mother of a son required to carry an EpiPen®.

Featured Insights
  • The EpiPen Price Increase: A Deeper Look at a Complicated Story
    Learn More
  • DST Health Solutions Leadership: Rayvelle Stallings VP, Government Programs
    Learn More
  • Managing the Complexities of Prescription Opioid Misuse and Overuse
    Learn More

Subscribe for more info
Want to stay up to date? Subscribe to our communications to access the latest content.


For More Information